Login
$ALMR
$30.55 -$0.26 (0.84%) Live

$ALMR SEC Filings

Filed On Filing
13 Nov 2026 Form 4: Qiming Corporate Gp VI, Ltd., 10% owner and 6 others

Sold 100,117 shares ($2.94M)

05 Nov 2026 Form 4: Qiming Corporate Gp VI, Ltd., 10% owner and 6 others

Sold 111,313 shares ($3.33M)

04 Nov 2026 10-Q
03 Nov 2026 Form 4: Qiming Corporate Gp VI, Ltd., 10% owner and 6 others

Sold 143,706 shares ($4.37M) · Sold 43,930 shares ($1.31M)

03 Nov 2026 8-K: Results of Operations and Financial Condition; Departure/Election of Directors or Officers; Compensation

FREMONT, Calif. Nov. 03, 2026 (GLOBE NEWSWIRE) -- Alamar Biosciences, Inc. (Nasdaq: ALMR), a leader in precision proteomics dedicated to enabling the earliest detection of disease, today reported financial results for the quarter ended S...

29 Oct 2026 Form 4: Qiming Corporate Gp VI, Ltd., 10% owner and 6 others

Sold 84,894 shares ($2.66M) · Sold 100,837 shares ($3.3M)

27 Oct 2026 Form 4: Qiming Corporate Gp VI, Ltd., 10% owner and 6 others

Sold 147,934 shares ($4.53M) · Sold 132,524 shares ($4.04M)

23 Oct 2026 Form 4: Qiming Corporate Gp VI, Ltd., 10% owner and 6 others

Sold 208,815 shares ($6.33M) · Sold 133,811 shares ($3.92M)

21 Oct 2026 Form 4: Qiming Corporate Gp VI, Ltd., 10% owner and 6 others

Sold 75,508 shares ($1.99M) · Sold 142,004 shares ($3.96M)

19 Oct 2026 Form 4: Qiming Corporate Gp VI, Ltd., 10% owner and 6 others

Sold 173,537 shares ($4.81M) · Sold 136 shares ($3.67K)

14 Oct 2026 144
14 Oct 2026 144
14 Oct 2026 144
14 Oct 2026 144
16 Sep 2026 Form 4: Brottem John L., General Counsel

Received 29,000 shares as a grant or award · Granted 85,000 Employee Stock Option (right to buy)

16 Sep 2026 Form 3: Brottem John L., General Counsel

No securities owned

03 Sep 2026 Form 4: Ragusa Robert P, Director

Received 5,686 shares as a grant or award · Granted 25,599 Stock Option (Right to Buy)

03 Sep 2026 Form 3: Ragusa Robert P, Director

No securities owned

01 Sep 2026 8-K: Departure/Election of Directors or Officers; Compensation

On August 28, 2026, the board of directors (the “Board”) of Alamar Biosciences, Inc. (the “Company”) appointed Robert Ragusa to the Board, effective as of September 1, 2026. Mr. Ragusa will serve as a Class I Director, with an initial te...

13 Aug 2026 SCHEDULE 13G

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support